TARS
NASDAQ · Pharmaceuticals
Tarsus Pharmaceuticals Inc
$67.45
-1.62 (-2.35%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+20.9% upside
Low Target
$66.63
Average Target
$81.52
High Target
$107.19
Current Price
$67.45
Current
$67.45
$67.45
Target
$81.52
$81.52
$66.63
$81.52 avg
$107.19
Scenario Analysis
Bear Case
$66.63
-1.2%
Low target
Base Case
$81.52
+20.9%
Avg target
Bull Case
$107.19
+58.9%
High target
Risk/Reward
48.5x
Highly favorable
Price in Context
52-Week High
$91.53
-26.3% from high
52-Week Low
$53.89
+25.2% from low
50-Day SMA
$75.12
-10.2% vs SMA
200-Day SMA
$67.78
-0.5% vs SMA
RSI (14)
46.0
Neutral
Target vs 52W High
$81.52
-10.9% vs high
Next Earnings Report
Nov 10, 2026
3d
until earnings
EPS Est: $-2.79
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals